Latest filing published 12 Feb 2026 for COLLEGIUM PHARMACEUTICAL, INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Thomas B. Smith (senior executive) discloses dealings in 2 companies, chiefly Collegium Pharmaceutical, Inc and Biodelivery Sciences International Inc. The record holds 9 filings, for trades running from 27 January 2022 to 10 February 2026.
The open-market record consists of 3 sales worth €926k, with no purchase. The rest of the record consists of 4 share grants and 1 option exercise.
Most recently, on 12 February 2026, the filings show a share grant in Collegium Pharmaceutical, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations